Claims for Patent: 9,198,871
✉ Email this page to a colleague
Summary for Patent: 9,198,871
| Title: | Delayed release pancreatin compositions |
| Abstract: | An enteric-coated oral dosage form comprising an acid labile active pharmaceutical ingredient where the composition is substantially free of monomeric phthalic acid esters and synthetic oils is described herein. Also provided are methods for making and using the enteric-coated oral dosage form. The disclosed pharmaceutical compositions comprise an enteric coating which includes at least one plasticizer, at least one film-forming agent and optionally at least one anti-sticking agent. |
| Inventor(s): | George Shlieout, Claus-Juergen Koelln, Frithjof Sczesny, Jens Onken, Andreas Koerner |
| Assignee: | Abbott Products GmbH |
| Application Number: | US11/464,754 |
Details for Patent 9,198,871
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Abbvie Inc. | CREON | pancrelipase | Capsule, Delayed Release | 020725 | April 30, 2009 | ⤷ Get Started Free | 2026-08-15 |
| Abbvie Inc. | CREON | pancrelipase | Capsule, Delayed Release | 020725 | June 10, 2011 | ⤷ Get Started Free | 2026-08-15 |
| Abbvie Inc. | CREON | pancrelipase | Capsule, Delayed Release | 020725 | March 14, 2013 | ⤷ Get Started Free | 2026-08-15 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 9,198,871
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2007020260 | ⤷ Get Started Free |
| World Intellectual Property Organization (WIPO) | 2007020259 | ⤷ Get Started Free |
| United States of America | 2024226249 | ⤷ Get Started Free |
| United States of America | 2024148660 | ⤷ Get Started Free |
| >Country | >Patent Number | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
